Chen Chu-Hsuan, Hsu Sheng-Yun, Yu Wen-Jui, Chiang Chi-Shiun, Yu Ching-Fang
Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsin-Chu, Taiwan.
Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsin-Chu, Taiwan.
J Cancer. 2025 Jan 1;16(3):969-981. doi: 10.7150/jca.103595. eCollection 2025.
Previous studies revealed that tumor-associated macrophages/microglia (TAMs) promoted glioma invasiveness during tumor progression and after radiotherapy. However, the communication of TAMs with tumor cells remains unclear. This study aimed to examine the role of small extracellular vesicles (sEVs) derived from TAMs in TAMs-mediated brain tumor invasion. This study utilized BV2 and RAW264.7 cell lines representing resident and infiltrating macrophages, respectively, to unveil their effect on tumor cells. Purified sEVs from BV2 and RAW264.7 were validated by nanoparticle track analysis (NTA), transmission electron microscopy (TEM), and western blotting for sEV markers. The effect of sEVs on the murine astrocytoma tumor cell line ALTS1C1 was examined on cell proliferation, migration, and gene expression. The results showed that ALTS1C1 cells effectively engulfed sEVs purified from BV2 and RAW264.7. Only BV2-derived sEVs promoted cell proliferation and were dose-dependent. Further, morphological changes in ALTS1C1 cells were observed after incubation with BV2-derived sEVs, which was associated with enhancing cell migration. BV2-mediated glioma proliferation and mobility were related to the upregulation of vascular endothelial growth factor (VEGF) and downregulation of death effector domain-containing protein (DEDD) gene expression. This study demonstrates the distinct function of sEVs of resident macrophages on glioma cell invasion and reveals the mechanism underlying microglia-mediated tumor progression. These findings suggested resident microglia is the potential therapeutic target for TAMs-induced brain tumor invasiveness.
先前的研究表明,肿瘤相关巨噬细胞/小胶质细胞(TAMs)在肿瘤进展过程中和放疗后促进了胶质瘤的侵袭性。然而,TAMs与肿瘤细胞之间的通讯仍不清楚。本研究旨在探讨源自TAMs的小细胞外囊泡(sEVs)在TAMs介导的脑肿瘤侵袭中的作用。本研究分别利用代表常驻巨噬细胞和浸润巨噬细胞的BV2和RAW264.7细胞系,以揭示它们对肿瘤细胞的影响。通过纳米颗粒跟踪分析(NTA)、透射电子显微镜(TEM)和针对sEV标志物的蛋白质印迹法,对从BV2和RAW264.7中纯化的sEVs进行了验证。研究了sEVs对小鼠星形细胞瘤肿瘤细胞系ALTS1C1的细胞增殖、迁移和基因表达的影响。结果表明,ALTS1C1细胞有效地吞噬了从BV2和RAW264.7中纯化的sEVs。只有源自BV2的sEVs促进细胞增殖,且呈剂量依赖性。此外,在用源自BV2的sEVs孵育后,观察到ALTS1C1细胞的形态变化,这与增强细胞迁移有关。BV2介导的胶质瘤增殖和迁移与血管内皮生长因子(VEGF)的上调和含死亡效应结构域蛋白(DEDD)基因表达的下调有关。本研究证明了常驻巨噬细胞的sEVs在胶质瘤细胞侵袭中的独特功能,并揭示了小胶质细胞介导的肿瘤进展的潜在机制。这些发现表明,常驻小胶质细胞是TAMs诱导的脑肿瘤侵袭性的潜在治疗靶点。